Getinge AB logo

Getinge AB (GNGBF)

Market Closed
11 Dec, 20:00
OTC PINK OTC PINK
$
21. 00
0
0%
$
5.14B Market Cap
24.02 P/E Ratio
1.67% Div Yield
0 Volume
0 Eps
$ 21
Previous Close
Day Range
21 21
Year Range
15.62 21.11
Want to track GNGBF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 42 days

Summary

GNGBF closed Thursday higher at $21, an increase of 0% from Wednesday's close, completing a monthly increase of 0% or $0. Over the past 12 months, GNGBF stock gained 34.44%.
GNGBF pays dividends to its shareholders, with the most recent payment made on Apr 29, 2025. The next estimated payment will be in In 4 months on Apr 29, 2026 for a total of $0.4784.
The last earnings report, released on Oct 21, 2025, missed the consensus estimates by -2.42%. On average, the company has fell short of earnings expectations by -1.42%, based on the last three reports. The next scheduled earnings report is due on Jan 26, 2026.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

GNGBF Chart

Similar

Sino Biopharmaceutical Limited
$ 0.86
-1.11%
SKF AB
$ 25.25
0%
Bangkok Dusit Medical Services Public Company Limited
$ 0.59
0%
Sysmex Corporation
$ 9.33
0%
Alibaba Health Information Technology Ltd.
$ 14.82
0%
Getinge AB (publ) (GNGBF) Q2 2025 Earnings Call Transcript

Getinge AB (publ) (GNGBF) Q2 2025 Earnings Call Transcript

Getinge AB (publ) (OTCPK:GNGBF) Q2 2025 Earnings Conference Call July 18, 2025 4:00 PM ET Company Participants Agneta Palmer - Chief Financial Officer Mattias Perjos - CEO, President & Director Conference Call Participants Aisyah Noor - Morgan Stanley, Research Division Anchal Verma - JPMorgan Chase & Co, Research Division Erik Cassel - Danske Bank A/S, Research Division Kristofer Liljeberg-Svensson - DNB Carnegie, Research Division Ludwig Germunder - Handelsbanken Capital Markets AB, Research Division Mattias Vadsten - SEB, Research Division Sten Gustafsson - ABG Sundal Collier Holding ASA, Research Division Operator [Audio Gap] 2025 presentation. [Operator Instructions] Now I will hand the conference over to the speakers, CEO, Mattias Perjos; and CFO, Agneta Palmer.

Seekingalpha | 4 months ago
Getinge AB (publ) (GNGBF) Q1 2025 Earnings Call Transcript

Getinge AB (publ) (GNGBF) Q1 2025 Earnings Call Transcript

Getinge AB (publ) (OTCPK:GNGBF) Q1 2025 Earnings Conference Call April 22, 2025 7:00 AM ET Company Participants Mattias Perjos - President & CEO Agneta Palmer - Chief Financial Officer Conference Call Participants Rickard Anderkrans - Handelsbanken Mattias Vadsten - SEB Erik Cassel - Danske Bank Markets Kristofer Liljeberg-Svensson - Carnegie Investment Bank Sten Gustafsson - ABG Sundal Collier Aisyah Noor - Morgan Stanley David Adlington - JPMorgan Operator Welcome to the Getinge Q1 Report 2025. [Operator Instructions].

Seekingalpha | 7 months ago
Getinge AB (GNGBF) Q4 2024 Earnings Call Transcript

Getinge AB (GNGBF) Q4 2024 Earnings Call Transcript

Getinge AB (OTCPK:GNGBF) Q4 2024 Results Conference Call January 28, 2025 4:00 AM ET Company Participants Mattias Perjos - President & CEO Agneta Palmer - CFO Conference Call Participants Rickard Anderkrans - Handelsbanken Erik Cassel - Danske Bank Aisyah Noor - MS Mattias Vadsten - SEB Kristofer Liljeberg - Carnegie Investment Bank Patrik Ling - DNB Markets Operator Welcome to the Getinge Q4 Report 2024. [Operator Instructions] Now I will hand the conference over to speakers CEO, Mattias Perjos; and CFO, Agneta Palmer.

Seekingalpha | 10 months ago

Getinge AB (GNGBF) FAQ

What is the stock price today?

The current price is $21.00.

On which exchange is it traded?

Getinge AB is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is GNGBF.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.67%.

What is its market cap?

As of today, the market cap is 5.14B.

When is the next earnings date?

The next earnings report will release on Jan 26, 2026.

Has Getinge AB ever had a stock split?

No, there has never been a stock split.

Getinge AB Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Mattias Perjos M.Sc. CEO
OTC PINK Exchange
SE0000202624 ISIN
SE Country
11,827 Employees
24 Apr 2025 Last Dividend
- Last Split
- IPO Date

Overview

Getinge AB (publ) is a global provider of products and solutions targeted at improving efficiencies and outcomes in operating rooms, intensive-care units, sterilization departments, and more. Established in 1904 and based in Gothenburg, Sweden, the company enriches healthcare facilities worldwide through its three operative segments: Acute Care Therapies, Life Science, and Surgical Workflows. It is dedicated to offering a wide range of medical technologies and services, catering to the critical areas of patient care and scientific processes. Getinge stands out for its comprehensive product portfolio that addresses complex healthcare challenges, aiming for innovation in patient care and clinical results. The company extends its reach through an extensive network of sales companies and partners across the Americas, Europe, the Middle East, Africa, and the Asia Pacific regions, ensuring its solutions are accessible globally.

Products and Services

  • Extracorporeal membrane oxygenation (ECMO), mechanical ventilation, and mechanical circulatory support:

    These are life-saving therapies for patients in critical conditions, offering support for heart and lung functions.

  • Advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions:

    Comprehensive patient monitoring and management systems designed for the intensive care environment, improving patient flow and care efficiency.

  • Surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions:

    Essential tools and technologies for cardiac surgery, enhancing surgical outcomes and patient recovery.

  • Operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions:

    State-of-the-art solutions for the operating room, facilitating better coordination, safety, and efficiency during surgical procedures.

  • Pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices:

    Comprehensive infection control solutions that ensure the cleanliness and sterility of medical devices and environments, backed by advanced connectivity for seamless operations.

  • Bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers:

    Advanced solutions supporting the life science industry in drug development and manufacturing processes with a focus on sterility and containment.

  • Vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions:

    Equipment and systems designed for research labs and bioprocessing facilities, ensuring safe handling of materials and sterility for bioprocessing applications.

Contact Information

Address: Lindholmspiren 7A
Phone: 46 1 03 35 00 00